Drug Trial Radar · NCT07502508
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Apr 30, 2026
Primary completion
Jun 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- Biomea Fusion Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 31, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes (T2D) not achieving glycemic targets despite GLP-1-based therapy.
Conditions
- Type 2 Diabetes
Interventions
icovamenib 100 mgDrug
icovamenib 100 mg
PlaceboDrug
Matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- To demonstrate that icovamenib 100 mg once daily for 12 weeks is superior to placebo for glycemic controlTime frame: 26 weeks
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Central Research Associates, LLC dba Flourish Research
Birmingham, Alabama · Recruiting
Hope Clinical Research
Canoga Park, California · Recruiting
Ark Clinical Research
Long Beach, California · Recruiting
Catalina Research Institute, LLC
Montclair, California · Recruiting
Paradigm Clinical Research Centers, LLC
San Diego, California · Recruiting
Southwest General Healthcare Center
Fort Myers, Florida · Recruiting
Panax Clinical Research
Miami Lakes, Florida · Recruiting
Flourish Research Orlando
Winter Park, Florida · Recruiting
Centricity Research, Endocrine Consultants PC
Columbus, Georgia · Recruiting
David Kavtaradze MD, Inc
Cordele, Georgia · Recruiting
Excel Clinical Research
Las Vegas, Nevada · Recruiting
Centricity Research, Lucas Research, Inc.
Morehead City, North Carolina · Recruiting
Diabetes and Endocrinology Associates of Stark County
Canton, Ohio · Recruiting
Elligo Health Research, Inc.
Austin, Texas · Recruiting
Zenos Clinical Research
Dallas, Texas · Recruiting
Synergy Group Medical
Houston, Texas · Recruiting
Epic Clinical Research
Lewisville, Texas · Recruiting
Synergy Group Medical
Missouri City, Texas · Recruiting
Diabetes & Glandular Disease Clinic, P.A.
San Antonio, Texas · Recruiting
Burke Internal Medicine and Research
Burke, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.